L-Alanyl-L-leucine

CAS No. 3303-34-2

L-Alanyl-L-leucine( —— )

Catalog No. M37624 CAS No. 3303-34-2

L-Alanyl-L-leucine (H-Ala-Leu-OH) is a dipeptide compound that is involved in protein synthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 In Stock
50MG 37 In Stock
100MG 60 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-Alanyl-L-leucine
  • Note
    Research use only, not for human use.
  • Brief Description
    L-Alanyl-L-leucine (H-Ala-Leu-OH) is a dipeptide compound that is involved in protein synthesis.
  • Description
    L-Alanyl-L-leucine is an endogenous metabolite.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Endogenous Metabolite
  • Recptor
    Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3303-34-2
  • Formula Weight
    202.25
  • Molecular Formula
    C9H18N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 1 mg/mL (4.94 mM; Ultrasonic (<60°C)
  • SMILES
    [C@H](NC([C@H](C)N)=O)(CC(C)C)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2-Ethylpyrazine

    2-Ethylpyrazine is present in roasted coffee beans and is a volatile compound .2-Ethylpyrazine induces vasodilation through the activity of endothelium-derived relaxing factors.

  • Diethyl oxalpropiona...

    Diethyl oxalpropionate also known as methyloxalacetic acid diethyl ester or diethyl methyloxalacetate is a member of the class of compounds known as beta-keto acids and derivatives. These compounds are organic compounds containing an aldehyde substituted with a keto group on the C3 carbon atom.

  • Cholesteryl oleate

    Cholesteryl oleate is a cholesteryl ester. Cholesteryl oleate can be used to synthesize solid lipid nanoparticles which is a nanoparticle-based gene therapy approach.